Careers  |  Sign In  |  Register  |   Twitter

Latest in Rheumatology

Reuters Health • The Doctor's Channel Daily Newscast

Disease-activity score helps guide treatment of new-onset RA

NEW YORK (Reuters Health) - In recent-onset active rheumatoid arthritis (RA), regular medication adjustments based on disease-activity scores (DAS) improves clinical outcomes and possibly radiological outcomes as well, a Dutch study shows. The study results underscore the observation that “patients are...

Reuters Health • The Doctor's Channel Daily Newscast

Hylan G-F 20 injection reduces knee osteoarthritis pain for 6 months

NEW YORK (Reuters Health) - A single 6-mL intra-articular injection of hylan G-F 20 (Synvisc-One, Genzyme Biosurgery) safely reduces knee osteoarthritis pain for 26 weeks, results of a prospective European trial suggest. Lead researcher Dr. Xavier Chevalier and associates explain in the January issue of...

Reuters Health • The Doctor's Channel Daily Newscast

Abatacept does not increase malignancies in rheumatoid arthritis patients

NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA), according to researchers reporting on clinical trial safety data. Abatacept is effective in RA, but its...